BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li DK, Chung RT. Use of proton pump inhibitors in chronic liver diseases. Clin Liver Dis (Hoboken) 2017;10:148-51. [PMID: 30992776 DOI: 10.1002/cld.678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mak LY, Fung J. Proton pump inhibitors in chronic liver disease: accomplice or bystander? Hepatol Int 2020;14:299-301. [PMID: 32304088 DOI: 10.1007/s12072-020-10033-1] [Reference Citation Analysis]
2 Song HJ, Jiang X, Henry L, Nguyen MH, Park H. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis. Eur J Clin Pharmacol 2020;76:851-66. [PMID: 32172363 DOI: 10.1007/s00228-020-02854-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhang ZL, Peng MS, Chen ZM, Long T, Wang LS, Xu ZL. Effect of aluminum phosphate gel on prevention of early rebleeding after ligation of esophageal variceal hemorrhage. World J Gastrointest Surg 2021;13:1651-9. [PMID: 35070070 DOI: 10.4240/wjgs.v13.i12.1651] [Reference Citation Analysis]
4 Kim TJ, Lee H. Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors. Korean J Helicobacter Up Gastrointest Res 2020;20:196-203. [DOI: 10.7704/kjhugr.2020.0014] [Reference Citation Analysis]
5 Ghoz H, Patel P, Stancampiano F, Patel S, Fox EA, Yousaf MB, Omer M, Heckman MG, Spiegel MR, Palmer WC. Proton-pump-inhibitor use associated with lower short-term rebleeding and mortality in patients receiving esophageal variceal band ligation: a retrospective cohort study. Eur J Gastroenterol Hepatol 2020;32:1571-8. [PMID: 32868651 DOI: 10.1097/MEG.0000000000001905] [Reference Citation Analysis]